Yuasa et al. (2016) found that CTRP1 upregulation might be a compensatory regulatory response to alleviate metabolic diseases and heart diseases. The level of adiponectin in blood is significantly reduced in patients and animal models of stroke (Ilhan et al., 2019; Yang et al., 2019). The gene discussed is ADIPOQ; the disease is metabolic disease.